NJ-J.M.-HUBER
Huber Engineered Materials (HEM), a leading global producer of specialty performance ingredients for industrial and consumer products and a division of the J.M. Huber Corporation (Huber), announces that Dan Krawczyk has been appointed HEM President, effective Nov. 1, 2017. Krawczyk remains a member of the HEM Board of Directors and Huber Management Council.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171114006056/en/
Before becoming the President of HEM, Krawczyk served as Huber’s Executive Vice President (EVP) of Strategy & Corporate Development since 2013. He brings more than 20 years of experience in industrial and consumer products, including expertise in financial management, strategy, corporate development, marketing and operations to his new leadership role. A native of the Detroit area, Krawczyk earned an MBA as well as an MS and BS in Electrical Engineering from the University of Michigan.
Prior to joining Huber, Krawczyk was EVP and Chief Financial Officer of Gibson Guitar Corporation. He also was Global Vice President of Business Development and Strategic Marketing for Belden and has held financial and operational leadership roles at DTE Energy, Delphi Automotive and Ford Motor Company.
Looking ahead, Krawczyk plans to lead HEM into a new era of growth and change in order to successfully position the company for future generations of shareholders and employees.
“Building on a strong track record of focused market leadership, superior customer service and operational excellence, HEM has a unique opportunity today to leverage its manufacturing and applications expertise in order to pursue growth in its core businesses and expand across a range of premium functional ingredient business segments,” Krawczyk said. “We look forward to creating long-term sustainable value for all the HEM stakeholders.”
Krawczyk’s leadership was instrumental in Huber’s largest acquisition in over 10 years, the 2016 purchase of the Martinswerk business from Albemarle Corporation to become part of HEM’s already successful Fire Retardant Additives (FRA) business unit and create a global leading non-halogen flame retardants business. This move marked the latest in a series of investments in FRA, including the acquisition of the Kemgard® smoke suppressant product line from Sherwin-Williams in 2010 and purchase of the Almatis specialty hydrates business in 2012. In addition, Krawczyk led Huber’s $630 million sale of HEM’s Silica business unit to Evonik Industries AG in 2017.
About Huber Engineered Materials (www.hubermaterials.com )
Huber Engineered Materials, headquartered in Atlanta, Georgia (US), is a global business focused on engineered specialty ingredients that enhance the performance, appeal and processing of a broad range of products used in industrial and consumer-based applications. With an expertise in inorganic materials, it has a portfolio of high value products: alumina trihydrate, magnesium hydroxide, molybdate compounds, specialty aluminas and oxides, organic matting agents, barium sulfate and industrial, food and USP grade calcium carbonate.
About J.M. Huber Corporation (www.huber.com )
J.M. Huber Corporation, headquartered in Edison, New Jersey (US), operates a portfolio of companies with a focus on its core engineered materials businesses. Founded in 1883, Huber is one of the largest family-owned companies in the US. The diversified, multinational company creates products that are used in a broad range of consumer and industrial applications, including personal care, food, beverage, pharmaceuticals and building materials.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171114006056/en/
Contact:
Huber Engineered Materials
Keith Sorrell, 678-247-2730
keith.sorrell@huber.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OpZira, Inc. Launches to Advance Ophthalmic Diagnostics with Innovative Medical Device Portfolio3.9.2025 19:23:00 CEST | Press release
OpZira™, Inc., a forward-thinking ophthalmic medical device company founded on a legacy of research excellence, today announced its official formation. OpZira is dedicated to delivering innovative technologies that enhance the detection and monitoring of ocular disease, empowering clinicians with advanced diagnostic tools. OpZira’s creation follows Alcon’s acquisition of LumiThera (https://www.alcon.com/media-release/alcon-completes-acquisition-lumithera/) and its innovative Valeda® Light Delivery System, the first and only FDA-authorized treatment for dry age-related macular degeneration (AMD). As part of the transaction, LumiThera’s diagnostic product lines were spun off to LumiThera shareholders, leading to the establishment of OpZira, Inc. OpZira’s product portfolio includes: AdaptDx Pro® – A wearable dark adaptometer that leverages AI to ensure a consistent patient experience. Impaired dark adaptation speed, a key early indicator of rod-mediated dysfunction, is often among the fir
BTG Bioliquids and NanosTech Partner to Deliver End-to-End Advanced Biofuels Solution3.9.2025 18:19:00 CEST | Press release
BTG Bioliquids BV (BTL), a Netherlands-based leader in fast pyrolysis technology, and NanosTech Technology & Innovations Ltd. (NanosTech), a Canada-based catalyst development and manufacturing company, have signed a Memorandum of Understanding (MOU) to deliver a fully integrated solution to produce advanced, drop-in biofuels. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903698730/en/ The partnership combines BTL’s proven fast pyrolysis technology, which converts sustainable biomass into bio-oil, with NanosTech’s proprietary Aquaprocessing (AQP) platform, which upgrades even the most challenging bio-oils into refinery-ready feedstocks to produce fuels such as sustainable aviation fuel (SAF), renewable diesel, and marine fuels. The two companies are now actively collaborating to determine the location in Canada and Europe for the new 500-barrel-per-day modular biorefinery system. This system can be deployed near the feeds
Armis Named a Leader in IoT Security Solutions, Q3 2025 Evaluation3.9.2025 15:58:00 CEST | Press release
Recognition follows Armis being named a Leader in Unified Vulnerability Management Solutions evaluation Armis, the cyber exposure management & security company, today announced that it has been named a Leader in The Forrester Wave™: IoT Security Solutions, Q3 2025. This achievement comes on the heels of Armis being named a Leader in The Forrester Wave™: Unified Vulnerability Management Solutions, Q3 2025. In this Forrester Wave™, Armis is ranked a Leader and achieved the highest scores possible in 9 key criteria. According to the report, “Armis’ vision centers on delivering enterprise-wide exposure management that goes beyond IoT and OT devices. Its innovation investments and acquisitions support this goal. Its roadmap aligns with customer priorities while anticipating future needs to ensure the platform evolves alongside its clients. This forward-looking strategy fosters successful adoption and helps customers deploy the Centrix platform successfully.” “We’re proud to once again be re
Rapid Medical™ Surpasses 1,000 Cases With DRIVEWIRE™ 24 in North America and Expands Into Europe With MDR Approval3.9.2025 15:46:00 CEST | Press release
Clinical performance and strong physician demand drive swift uptake and global approval of next-generation access technology Rapid Medical™, a leading developer of active endovascular devices, announces that its DRIVEWIRE™ 24 steerable guidewire has been used in more than 1,000 neurovascular procedures in North America during a limited commercial launch beginning earlier this year. The company also announced receipt of CE Mark under the European Medical Device Regulation (MDR), as presented at the 2025 ESMINT Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903530140/en/ “In my experience, the wire provides a unique combination of precision and support that simply hasn’t been possible with conventional technologies,” stated Dr. Erez Nossek, a neurosurgeon at NYU Langone in New York, NY. “It has become a reliable tool that allows us to approach any anatomy with greater efficiency and less time.” As the first
Ondo Finance and Alpaca Collaborate to Tokenize US Stocks and ETFs3.9.2025 15:30:00 CEST | Press release
Bridging traditional finance and on-chain markets, increasing access to high-quality assets Today, Ondo Finance, a leader in blockchain-based financial innovation and tokenized real-world assets, announced the launch of Ondo Global Markets, their platform for tokenized US stocks and ETFs. The platform is powered by a strategic integration with Alpaca, a self-clearing broker-dealer and brokerage infrastructure API for stocks, ETFs, and options trading, as well as crypto. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903244835/en/ Ondo Finance and Alpaca collaborate to tokenize US stocks and ETFs; bridging traditional finance and on-chain markets, increasing access to high-quality assets. According to a McKinsey report, the tokenized market capitalization could reach around $2 trillion by 2030 across a variety of asset classes. This expected rise in market demand for tokenized assets, like US stocks and ETFs, comes as glob
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom